SCHEMBL13434162

SCHEMBL13434162

CCCN(C(=O)CCCC(N)=O)C1CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35
ADH1A P07327 3/20 0.35
ADH1C P00326 2/20 0.35
ADH4 P08319 1/20 0.35
ALDH1A1 P00352 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MEN1 O00255 1/20 0.33
FAAH O00519 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
SOAT1 P35610 1/20 0.33
KMT2A Q03164 1/20 0.33
LTB4R2 Q9NPC1 1/20 0.33
PKM P14618 1/20 0.33
SLC6A4 P31645 3/20 0.32
KCNH2 Q12809 1/20 0.32
OPRM1 P35372 2/20 0.32
CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13434163 0.91 PKM (0.36) ADH1AADH1CALDH1A1L3MBTL1MEN1
SCHEMBL13434164 0.86 PKM (0.41) ALDH1A1MEN1KMT2APKM
SCHEMBL13434160 0.86 ALDH1A1 (0.52) LMNAADH1AADH1CADH4ALDH1A1
SCHEMBL5987559 0.84 LTB4R2 (0.36) LMNAADH1AADH1CADH4ALDH1A1
SCHEMBL13434161 0.82 TSHR (0.47) LMNAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL13434173 0.81 PDE3B (0.37) LMNAALDH1A1L3MBTL1MEN1CYP3A4
SCHEMBL5985502 0.80 SMYD3 (0.37) ADH1AADH1CALDH1A1L3MBTL1LTB4R2
SCHEMBL5986502 0.79 PTGS1 (0.34) L3MBTL1PKMSLC6A4KCNH2SLC6A2
SCHEMBL13434137 0.79 PKM (0.49) ALDH1A1L3MBTL1MEN1KMT2APKM
SCHEMBL18576497 0.77 OPRM1 (0.43) ADH1AADH1CALDH1A1L3MBTL1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056497-A1 AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2010-03-04 US disclosed
US-20100056497-A1 AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2010-03-04 US disclosed
EP-2119702-A1 AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2009-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056497-A1 AMIDE DERIVATIVE REN, AGTR1, AGTR2 LMNA 2412/4885ADH1A 80/4885ADH1C 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.